311 related articles for article (PubMed ID: 30790684)
21. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.
Liu B; Tang L; Zhang X; Ma J; Sehgal M; Cheng J; Zhang X; Zhou Y; Du Y; Kulp J; Guo JT; Chang J
Antiviral Res; 2017 Nov; 147():37-46. PubMed ID: 28982551
[TBL] [Abstract][Full Text] [Related]
22. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
23. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
[TBL] [Abstract][Full Text] [Related]
24. cGAS-STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells.
Suter MA; Tan NY; Thiam CH; Khatoo M; MacAry PA; Angeli V; Gasser S; Zhang YL
Sci Rep; 2021 Mar; 11(1):7243. PubMed ID: 33790360
[TBL] [Abstract][Full Text] [Related]
25. Bioactive modulators targeting STING adaptor in cGAS-STING pathway.
Feng X; Liu D; Li Z; Bian J
Drug Discov Today; 2020 Jan; 25(1):230-237. PubMed ID: 31758915
[TBL] [Abstract][Full Text] [Related]
26. Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application.
Pu F; Chen F; Liu J; Zhang Z; Shao Z
Onco Targets Ther; 2021; 14():1501-1516. PubMed ID: 33688199
[TBL] [Abstract][Full Text] [Related]
27. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
[TBL] [Abstract][Full Text] [Related]
28. Targeting STING for cancer immunotherapy: From mechanisms to translation.
Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
[TBL] [Abstract][Full Text] [Related]
29. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
30. SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis.
Song C; Liu D; Liu S; Li D; Horecny I; Zhang X; Li P; Chen L; Miller M; Chowdhury R; Issa M; Shen R; Yan Y; Zhang F; Zhang L; Zhang L; Bai C; Feng J; Zhuang L; Zhang R; Li J; Wilkinson H; Liu J; Tao W
Sci Rep; 2022 May; 12(1):8579. PubMed ID: 35595822
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Non-Nucleotide Small-Molecule STING Agonists
Cherney EC; Zhang L; Lo J; Huynh T; Wei D; Ahuja V; Quesnelle C; Schieven GL; Futran A; Locke GA; Lin Z; Monereau L; Chaudhry C; Blum J; Li S; Fereshteh M; Li-Wang B; Gangwar S; Pan C; Chong C; Zhu X; Posy SL; Sack JS; Zhang P; Ruzanov M; Harner M; Akhtar F; Schroeder GM; Vite G; Fink B
J Med Chem; 2022 Feb; 65(4):3518-3538. PubMed ID: 35108011
[TBL] [Abstract][Full Text] [Related]
32. SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS-STING Activation and Chemotherapeutic Sensitivity in Colon Cancer.
Wei B; Xu L; Guo W; Wang Y; Wu J; Li X; Cai X; Hu J; Wang M; Xu Q; Liu W; Gu Y
Cancer Res; 2021 Jun; 81(12):3215-3228. PubMed ID: 33820798
[TBL] [Abstract][Full Text] [Related]
33. STING modulators: Predictive significance in drug discovery.
Cui X; Zhang R; Cen S; Zhou J
Eur J Med Chem; 2019 Nov; 182():111591. PubMed ID: 31419779
[TBL] [Abstract][Full Text] [Related]
34. STING Signaling in Cancer Cells: Important or Not?
Sokolowska O; Nowis D
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
[TBL] [Abstract][Full Text] [Related]
35. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
McAndrews KM; Che SPY; LeBleu VS; Kalluri R
J Biol Chem; 2021; 296():100523. PubMed ID: 33711340
[TBL] [Abstract][Full Text] [Related]
36.
Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
[TBL] [Abstract][Full Text] [Related]
37. PCV2 infection activates the cGAS/STING signaling pathway to promote IFN-β production and viral replication in PK-15 cells.
Huang B; Zhang L; Lu M; Li J; Lv Y
Vet Microbiol; 2018 Dec; 227():34-40. PubMed ID: 30473349
[TBL] [Abstract][Full Text] [Related]
38. Remodeling of Tumor Microenvironment by Nanozyme Combined cGAS-STING Signaling Pathway Agonist for Enhancing Cancer Immunotherapy.
Dong W; Chen M; Chang C; Jiang T; Su L; Chen C; Zhang G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762239
[TBL] [Abstract][Full Text] [Related]
39. An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer.
An X; Zhu Y; Zheng T; Wang G; Zhang M; Li J; Ji H; Li S; Yang S; Xu D; Li Z; Wang T; He Y; Zhang L; Yang W; Zhao R; Hao D; Li X
Mol Ther Nucleic Acids; 2019 Mar; 14():80-89. PubMed ID: 30583098
[TBL] [Abstract][Full Text] [Related]
40. The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly.
Dansako H; Ueda Y; Okumura N; Satoh S; Sugiyama M; Mizokami M; Ikeda M; Kato N
FEBS J; 2016 Jan; 283(1):144-56. PubMed ID: 26471009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
